Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a smartphone app teach IBD patients to fight inflammation with food?

NCT ID NCT06683105

Recruiting now Symptom relief Sponsor: University of Alberta Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study tests whether the MyIBDDiet app helps people with inflammatory bowel disease (IBD) learn about and follow an anti-inflammatory diet. Forty adults with IBD who are not in a flare will use the app for 30 to 60 days and complete surveys about its ease of use and their diet quality. The goal is to see if the app is a useful tool for self-managing diet, not to prove the diet itself works.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
MyIBDDiet app (dietary education and self-management tool)
What this could lead to
If successful, this app could provide an easy way for people with IBD to learn about and follow an anti-inflammatory diet, potentially improving their symptoms and quality of life.
What could go wrong
This is a very small pilot study (40 people) focused on usability and acceptability, not on proving the diet itself works. The app may not lead to meaningful health changes, and results may not apply to everyone with IBD.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFLAMMATORY BOWEL DISEASE (IBD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Crohn disease inflammatory bowel disease Malnutrition ulcerative colitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INFLAMMATORY BOWEL DISEASE (IBD)

Contacts and locations

Locations

  • Zeidler Ledcor Centre, University of Alberta

    RECRUITING

    Edmonton, Alberta, T6G 2X8, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.